Clinical Trial Update: HEALEY ALS Platform Trial - Regimen B Verdiperstat [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 results for Verdiperstat under the HEALEY ALS Platform Trial in amyotrophic lateral sclerosis have been completed with results posted in 2023-06-12.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Verdiperstat (verdiperstat)

Snippet

Sponsor: Merit E. Cudkowicz, MD | Conditions: Amyotrophic Lateral Sclerosis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2023-06-12